DALE MICHAEL D
SEC CIK 1172346 · EDGAR
BoughtSold
Most active insiders at CVRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jain Mudit K. | Dir | $300.4K | — |
| 2 | Binkowski Brent | COO | $76.4K | $3,338 |
| 3 | Hykes Kevin | Pres, CEO, Dir | — | $61.3K |
| 4 | John Robert Allen | Chief Revenue Off | — | $31.3K |
| 5 | OASHEIM JARED | CFO | — | $13.8K |
| 6 | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | — | $10.1K |
| 7 | Adamson Philip B. | Chief Medical Off | — | $9,970 |
| 8 | SHADAN MARTHA | Dir | — | — |
| 9 | Hill, Mitch C. | Dir | — | — |
| 10 | Ballinger Kevin J. | Dir | — | — |
| 14 | DALE MICHAEL D | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-03 18:03 | 2026-06-01 | CVRX | CVRx, Inc. | DALE MICHAEL D | Dir | A - Grant | $0.00 | +29.0K | 29.0K | New | $0 |
| 2025-12-12 | 2025-12-10 | AXGN | Axogen, Inc. | DALE MICHAEL D | CEO | S - Sale | $30.00 | -25.0K | 63.5K | -28% | -$750.0K | |
| 2025-12-10 | 2025-12-09 | AXGN | Axogen, Inc. | DALE MICHAEL D | CEO | S - Sale | $31.21 | -61.5K | 88.5K | -41% | -$1.92M | |
| 2025-12-05 | 2025-12-04 | AXGN | Axogen, Inc. | DALE MICHAEL D | CEO | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 | |
| 2023-03-02 | 2023-03-01 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | S - Sale | $100.70 | -1,209 | 45.1K | -3% | -$121.7K | |
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | F - Tax | $99.77 | -4,942 | 46.3K | -10% | -$493.1K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | A - Grant | $0.00 | +9,504 | 51.3K | +23% | $0 |
| 2022-03-10 | 2022-03-08 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | S - Sale | $117.00 | -4,000 | 41.8K | -9% | -$468.0K | |
| 2022-03-02 | 2022-03-01 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | S - Sale | $118.15 | -1,053 | 45.8K | -2% | -$124.4K | |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | F - Tax | $122.41 | -4,505 | 46.8K | -9% | -$551.5K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | A - Grant | $0.00 | +11.6K | 51.3K | +29% | $0 |
| D | 2021-07-30 | 2021-07-28 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | S - Sale+OE | $120.33 | -17.6K | 39.7K | -31% | -$2.12M |
| D | 2021-07-30 | 2021-07-28 | ABT | Abbott Laboratories | DALE MICHAEL D | SVP | M - OptEx | $50.72 | +17.6K | 57.3K | +44% | +$892.7K |
Purchase Sale Sale after option exercise All abbreviations